You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Immunotherapy
 •Alert me on articles by topic

VIGNETTES
Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo in the Absence of UV-B Exposure

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The best results in vitiligo treatment with tacrolimus ointment have been obtained in summer and on UV light–exposed areas, which suggests that UV light enhances the efficacy of tacrolimus ointment.1-5 We performed a prospective intra-individual left/right comparison pilot study to evaluate the efficacy of 0.1% tacrolimus ointment as true monotherapy with no UV light exposure (artificial or natural).

Methods

Nine consecutive patients, each with at least 1 pair of symmetrical patches of vitiligo with similar evolution, were included in the study (Table 1). For each patient, 2 symmetrical target lesions were chosen in areas covered by clothes and protected from UV exposure. The entire study was performed in winter (December to February), and patients were asked to avoid UV exposure on the treated areas during the entire length of the study. Each lesion was treated twice daily with the 0.1% tacrolimus ointment (Protopic; Fujisawa Healthcare Inc, Deerfield, Ill) for . . . [Full Text of this Article]


Results

Comment

AUTHOR INFORMATION
Nima Ostovari, MD; Thierry Passeron, MD; Jean-Philippe Lacour, MD; Jean-Paul Ortonne, MD


RELATED LETTERS

Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure
Kabir Sardana, Premanshu Bhushan, and Vijay Kumar Garg
Arch Dermatol. 2007;143(1):119.
EXTRACT | FULL TEXT  

Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure—Reply
Thierry Passeron and Jean-Paul Ortonne
Arch Dermatol. 2007;143(1):120.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Successful Treatment of Vitiligo With 0.1% Tacrolimus Ointment
Lisa B. Travis, Jeffrey M. Weinberg, and Nanette B. Silverberg
Arch Dermatol. 2003;139(5):571-574.
EXTRACT | FULL TEXT  

A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo
Veronica Lepe, Benjamin Moncada, Juan Pablo Castanedo-Cazares, Maria Bertha Torres-Alvarez, Carlos A. Ortiz, and Antonio B. Torres-Rubalcava
Arch Dermatol. 2003;139(5):581-585.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure
Sardana et al.
Arch Dermatol 2007;143:119-119.
FULL TEXT  

Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure--Reply
Passeron and Ortonne
Arch Dermatol 2007;143:120-120.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.